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In 2019 we started a new annual meeting, aimed at bringing together researchers from 
across the UK studying cellular microbiology and the cell biology of host-pathogen 
interactions. In contrast to large glamourous meetings, featuring the great and the good 
from across the world, we wanted to create a forum for early career researchers to present 
their work and enjoy lively discussion. In particular, we hope that focussing on making the 
meeting accessible, affordable, and informal would help integrate and build the UK 




Following on from a highly successful inaugural meeting at the Francis Crick Institute last 
year (Rohn, Mostowy, King, Unnikrishnan, & Gutierrez, 2019), the second meeting of the UK 
Cellular Microbiology network was held at the University of Sheffield on the 10th of March 
2020. A traditionally quiet time for conferences, we were fortunate to hold it just before the 
COVID-19 pandemic took hold. Despite extensive travel chaos the evening before due to a 
strong storm, about 100 participants made it to Sheffield from across the UK, as well as a 
few other European countries, to attend an excellent day of talks and posters followed by a 
thorough debrief over a buffet dinner and drinks. This was all made possible thanks to 
generous sponsorship from the British Society of Cell Biology, Frontiers in Cellular and 
Infection Microbiology, and this journal – Cellular Microbiology. 
 
This year, the meeting was marked by the notable absence of Prof. Stefania Spanò 
(University of Aberdeen), who suddenly and tragically passed away at the end of last year. 
Stefania was a major contributor to the UK cellular microbiology field, and both a friend and 
collaborator to many at the meeting. She will be greatly missed by the community, and the 
best talk prizes were named in her honour in recognition of her achievements, and 
commitment to mentoring and nurturing new talent. 
 
The meeting was gracefully kicked off by the first of our keynote speakers, Annemarie 
Meijer from Leiden University, Netherlands. She demonstrated the power that zebrafish 
brings to the study of host-pathogen interactions and how she leverages that model to shed 
light on the mechanisms of host defence against intracellular bacterial pathogens 
responsible for infectious diseases, including tuberculosis and typhoid fever. One such 
defence is inflammasome activation, a key event that triggers inflammation whose role in 
tuberculosis disease progression is not well understood. Annemarie revealed new insights 
into the role of pyroptosis, a very specific cell death mechanism, in tuberculosis, with 
interesting links between nucleic acid sensing and Caspase 11-dependent pyroptosis. 
 
Zebrafish are being increasingly used to model human infection, and have also helped reveal 
key roles for neutrophils and emergency granulopoiesis in host defence against Shigella 
flexneri. Vincenzo Torraca (Wellcome / LSHTM ISSF Research Fellow in the Mostowy lab), who 
did an excellent job stepping in as a last-minute invitation, described how he uses zebrafish 
to investigate the virulence of Shigella sonnei, an emerging pathogen that is replacing S. 
flexneri as the principal cause of shigellosis in industrialized regions. Vincenzo discovered that 
S. sonnei is more virulent than S. flexneri in vivo because of its distinctive O-antigen which 
allows tolerance against phagolysosome acidification and resistance to neutrophil-mediated 
killing. 
 
Bacterial pathogens are known to interfere in a range of host immune responses. Charlotte 
Odendall (Kings College London) gave us an outstanding overview of the type I and III 
interferons and their signalling pathways, highlighting that these antiviral cytokines are also 
induced by many bacterial pathogens. Her research, which focuses on the enteric pathogen, 
Shigella, showed how OspC, a family of Shigella type III secretion system (T3SS) effectors, 
differentially blocks interferon I and III signalling. Interestingly, she discovered that 
interferon treatment protected epithelial barriers from Shigella invasion, indicating new 
antibacterial roles for these interferons at barrier sites. This is yet another example of how 
bacterial pathogens have evolved clever mechanisms to evade host defences. 
 
Many Gram-negative bacterial pathogens are masters at tweaking the innate immune 
response, paving the way for a smoother ride in the host. Salmonella enterica serovar 
Typhimurium is a good example of a bacteria that flexes this handy adaptation, injecting the 
cell with proteins that disarm host defences. One such protein is SteE, a bacterial effector 
that can activate a key transcriptional programme to establish an infection-permissive, anti-
inflammatory environment. Although previously the Thurston lab (Imperial College) had 
established that the host kinase GSK3, along with host transcription factor STAT3, were both 
involved in this process, no one knew how it worked. PhD student Ioanna Panagi and 
colleagues therefore set out to explore the mechanism. What they discovered was 
surprising: although GSK3 has always been thought to be a serine-threonine kinase, they 
were able to show that SteE converts both the amino acid and substrate specificity of GSK3, 
directing the kinase to phosphorylate STAT3 (not its usual substrate) on a tyrosine residue: 
Y705.  It is SteE that brings GSK3 and STAT3 together into a 3-way complex, thereby allowing 
the unusual phosphorylation event to take place. Such an unusual mechanism has never 
been reported before, and describes a novel trick by which bacteria can reprogramme host 
innate immune signalling.  
 
The survival tactics of Salmonella Typhimurium were also the subject of an entertaining talk 
from Anthony Davidson from the University of Cambridge (Vassilis Koronakis lab). Anthony’s 
talk focussed on how the bacteria gain entry into host cells by subversion of p21 activated 
kinase (PAK), which is best known for being a downstream target of the actin cytoskeletal 
regulators CDC42 and Rac1. Despite its importance, how PAK controls the cytoskeleton 
remains slightly enigmatic with the majority of PAK functions ascribed to its C-terminal 
kinase activity. Surprisingly, Anthony and colleagues discovered that this kinase activity is 
dispensable for infection by both S. Typhimurium and the extracellular pathogen 
enteropathogenic Escherichia coli (EPEC). Instead, the N-terminal scaffold domain of PAK 
appears to be key, via a series of four poly-proline motifs which directly interact with the 
Rac1/Cdc42 GEF β-PIX to facilitate bacterial invasion. This study puts the spotlight on a 
previously unappreciated role for the N-terminus of PAK in cytoskeletal control, beautifully 
demonstrating how pathogens remain powerful tools for unearthing new secrets in cell 
biology.  
 
Salmonella species encompass a large and diverse group of bacteria with varying ability to 
invade different hosts. Whilst typhoidal serovars are exquisitely restricted to humans, non-
typhoidal Salmonella (NTS) serovars are host generalists and cause zoonotic infections in 
humans. What are the factors that enable NTS serovar such as S. Typhimurium to infect a 
broad range of hosts? Natalia Cattelan from the University of Aberdeen showcased 
beautiful research from the Spanò lab, revealing how NTS disables the host protein Rab32 to 
bypass a novel bactericidal pathway in macrophages. This is achieved through the NTS-
specific virulence effectors SopD2 (Rab32 GAP protein) and GtgE (Rab32 protease), which 
are absent in typhoidal serovars, making them susceptible to the killing activity of Rab32 in a 
mouse model of infection. Intriguingly, Natalia revealed that GtgE, like Rab32, has a CaaX 
motif at its C-terminus, a prenylation signal for anchoring proteins in the membrane of 
eukaryotic cells. She showed that this motif was essential for GtgE localisation, and key for 
both NTS survival inside murine macrophages and for infection in vivo.  
 
Bacteria use a number of sophisticated mechanisms for antibiotic evasion, and in the era of 
increasing antibiotic resistance, more research is required to fully understand and tackle the 
problem. Kasia Mickiewicz (Newcastle University Faculty of Medical Sciences Research 
Fellow) won one of our best talk prizes for her excellent presentation on a little-known 
mechanism of antibiotic evasion referred to as ‘L-form switching’. L-form switching involves 
a temporary loss of bacterial cell wall rendering bacteria resilient to all classes of cell wall-
targeting antibiotics. A controversial concept when first proposed, Kasia demonstrated that 
L-form bacteria exist in patients with recurrent urinary tract infections, and used a zebrafish 
infection model to show that L-form switching can be adopted by pathogenic bacteria in 
vivo to evade cell wall-targeting antibiotics. 
 
The rise of multi-drug resistance is becoming particularly worrisome in the case of 
tuberculosis infection. To counter this, Phil Elks (standing in for his PhD student Ffion 
Hammond, University of Sheffield) described how they took the approach of targetting the 
host response, rather than the pathogen itself, to improve the outcome of infection.  Using 
a zebrafish tuberculosis model, Ffion found that trib1, a pseudokinase associated with 
immunity, was required for host protection against mycobacteria and overexpression of 
trib1 significantly reduced bacterial burden. Mechanistically, she demonstrated that trib1 
overexpression protects the host by causing an increased pro-inflammatory innate immune 
response, increasing production of pro-inflammatory factors il1β and nitric oxide. The 
zebrafish model is a novel tool to study trib1 and adds to increasing evidence that trib1 is 
involved in immune cell function, highlighting its potential as a host-derived therapeutic 
target. 
 
Whilst targeting the host immune response offers a promising way to counter infection, it is 
also frequently targeted by the pathogens themselves. For example, many pathogens 
enhance infection by modulating host cell survival through manipulation of cell death 
pathways, triggering pathways such as apoptosis to kill hostile macrophages or inhibiting 
death by pyroptosis to evade inflammatory responses. At the centre of cell death regulation 
are the host caspases. Intriguingly, it has become clear that low levels of caspase activation 
cause sub-lethal signaling of the mitochondrial apoptosis pathway, which promotes 
transformation and tumorigenesis. Remarkably, Dominik Brokatzky (PhD student in the 
Georg Häcker lab, Germany) described how sub-lethal apoptosis activation is hijacked by a 
range of pathogens during infection including viruses (Herpes simplex virus, Influenza A, 
modified vaccinia virus Ankara), bacteria (S. Typhimurium, Chlamydia trachomatis) and one 
parasite (Toxoplasma gondii). All these pathogens triggered this sub-lethal apoptosis 
activation through low-level activation of the mitochondrial apoptosis apparatus, inducing 
cytokine secretion from epithelial cells under control of the Bcl-2-protein family (Bax, Bak, 
Bcl-XL). Importantly, blocking Bax and Bak enhanced infection by both Salmonella and 
Chlamydia. Thus, Dominik revealed that sub-lethal apoptotic signalling provides a conserved 
cell-autonomous defence pathway against a broad array of pathogens. 
 
This year the meeting also embraced the growing field of fungal infections. Fungi are a 
major and growing cause of life threatening and debilitating infection in both the developed 
and the developing world. Candida species, and in particular Candida albicans, cause a high 
proportion of hospital-acquired infections each year in the UK and USA, causing significant 
mortality within the immunocompromised. Stella Christou (Ayscough lab, University of 
Sheffield) described how the fungal cell wall represents the major interaction surface 
between the pathogen and host cells, and altering its composition can both disrupt the 
physical properties of Candida and its ability to invade host cells. Previous work from the 
group showed that cell wall composition and structure is changed upon disruption of the 
AP-2 endocytic adaptor complex via deletion of the gene encoding APM4.  In her talk, Stella 
described how, despite being able to grow at a rate similar to wild type and retaining their 
ability to switch to their hyphal form in vitro, APM4-deficient Candida behaved differently in 
a range of infection models. Intriguingly, whilst hyphae still formed on epithelial 
monolayers, this capacity was severely impaired after engulfment by macrophages and in 
vivo in zebrafish. They propose that cell wall chitin might underpin important physical 
properties of hyphae that allow them to lyse macrophages and invade epithelia and 
endothelial layers but that these responses are nuanced by its interactions with the host.  
 
Host cells also deploy physical mechanisms to restrain pathogens. One example of this is via 
the septins, a poorly understood component of the host cytoskeleton, which entrap S. flexneri 
in cage-like structures to prevent actin-based motility. Although this role in suppressing 
infection is clear, the molecular determinants that underpin bacterial recognition and 
entrapment by septins are mostly unknown. To answer these questions, Dr. Damián Lobato-
Márquez (Marie Curie Postdoc Fellow in the Mostowy lab, LSHTM, and winner of the Stefania 
Spanò best talk prize, See Figure 1) developed an in vitro reconstitution assay based on 
purified septin proteins and host cell extracts. This ‘bottom-up’ approach enabled him to 
discover bacterial factors recognized by septins, and directly visualise septin assemblies on 
bacterial membranes using high-resolution microscopy. This elegantly demonstrated how in 
vitro reconstitution illuminate new concepts in cell biology that are difficult (or impossible) to 
address using whole cells or animal models. 
 
The scientific meeting came to an end with a very enlightening presentation from our 
second keynote speaker Jost Enninga from the Pasteur Institute in Paris, sponsored by 
Cellular Microbiology. Jost featured his recent Shigella research, both a technical tour de 
force and a testimony to the power of “seeing is believing”. Using different strategies to 
visualise the process of infection at the subcellular level, Jost showed, among other things, 
that Shigella and Salmonella subvert intracellular pathways regulated by Rab GTPases and 
the cytoskeleton to drive interactions with macropinosomes and create a niche for 
intracellular replication. The devil is in the details, and he nicely demonstrated how high-
resolution imaging approaches such as FIB-SEM can provide critical information about the 
places where bacteria replicate and the host components that contribute to this process. 
 
Thus concluded the second in this series of meetings, after which people moved on to a 
buffet dinner for some animated discussion and networking. The interactions and 
engagement from the audience during the talks and poster sessions were also excellent, 
providing a great forum for early career researchers to present their work. Whilst COVID-19 
restrictions may prevent a repeat of the meeting in person next February, we hope to build 
on the enthusiasm of the UK cellular microbiology community and maintain this forum for 
many years to come. 
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Figure 1: Damián Lobato-Márquez receiving his prize for the Stefania Spanò best talk award.  
